Nuclear Medicine

The Department of Nuclear Medicine of the Fourth Hospital of Harbin Medical University is a key discipline in imaging medicine and nuclear medicine in Heilongjiang Province, an authorized site for awarding doctoral and master's degrees and a postdoctoral research station in Heilongjiang Province, and a provincial-level Ministry of Health training base for nuclear medicine specialists; it is home to the National Health Commission Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy and the Heilongjiang Provincial Key Laboratory of Molecular Imaging, and is the site of the Heilongjiang Provincial Molecular Medicine Engineering Technology Research Center; it is a national base holding the “Radioactive Drug Use License (Class IV)” (top ten nationwide/the first in the three northeastern provinces), signifying that the department can take the lead in using and applying the world's most advanced radioactive diagnostic and therapeutic drugs and new molecular imaging diagnosis and treatment technologies in nuclear medicine, and can conduct the diagnosis and treatment of difficult and complex diseases. The department has an internationally advanced GE TOF-PET/CT/MR three-modality imaging system, the new Siemens e.camduet multifunctional nuclear medicine imaging equipment (SPECT/PET), a 16.5Mev cyclotron, an ultrahigh-field 3.0T magnetic resonance system, and an advanced radiopharmaceutical production and preparation system; its equipment and hardware configuration are at an internationally advanced level; the department also has a high-level radionuclide therapy ward, where it can provide clinical treatment with new radionuclide drugs integrating diagnosis and treatment, such as 177Lu. The department integrates medical care, teaching, and scientific research, and has 2 full professors and 4 associate professors; 2 doctoral supervisors and 4 master's supervisors; 72% of its physicians hold doctoral degrees, and many staff members have returned to China after advanced study and training at such world-class institutions as the Department of Nuclear Medicine of Stanford University School of Medicine, the University of Washington, the University of Georgia, and the University of North Carolina School of Medicine at Chapel Hill in the United States. In the field of nuclear medicine diagnosis and treatment, its disciplinary specialty is “precision diagnosis and treatment through molecular imaging”; it excels in comprehensive imaging diagnosis with PET/MR, PET/CT, and SPECT/CT, as well as radionuclide-based disease diagnosis and treatment, and has accumulated many years of experience in radionuclide therapy for bone metastases, hyperthyroidism, thyroid cancer, scars, and hemangiomas. Our department will provide our many patients with the highest-quality medical services through advanced equipment, first-rate technology, and innovative concepts.